The World's First Gene-Editing Therapy Targeting APOC3 for Hyperlipidemia
CorrectSequence Therapeutics' CS-121 Completed Dosing of First Chylomicronemia Patient, Demonstrating Excellent Safety and Significant Efficacy SHANGHAI, Nov. 6, 2025 /PRNewswire/ -- On November 6, 2025, Shanghai, China, CorrectSequence Therapeutics...
Netz Niederösterreich and Picarro Successfully Complete Large-Scale Methane Emissions Inspection Project Under New EU Regulation
SANTA CLARA, Calif. and MARIA ENZERSDORF, Austria, Nov. 4, 2025 /PRNewswire/ -- Picarro Inc., in collaboration with Netz Niederösterreich (Netz NÖ), has successfully completed a large-scale, short-timeline methane emissions inspection project in...
Hasten Sets a New Benchmark for Global Expansion by Building an End-to-End Asia-Pacific Healthcare Commercial Platform
SHANGHAI, Nov. 4, 2025 /PRNewswire/ -- Hasten Biopharmaceutical Co., Ltd. ("Hasten") announced that while completing 70 Marketing Authorization Transfers (MAT) for its Asia-Pacific product portfolio, the company has established an end-to-end...
Star Plus Legend Holdings Limited's Strategic Investment in Galaxy Signals Positive Momentum for Global IP Layout
GYEONGJU, South Korea, Nov. 3, 2025 /PRNewswire/ -- On November 3, 2025, Hong Kong-listed company Star Plus Legend Holdings Limited (Stock Code: 06683.HK) issued an announcement stating that it has completed a strategic investment in Galaxy, a...
Hankook GEN3 Evo iON Race Tire Delivers Under Pressure in Valencia
Four-day pre-season testing successfully completed at Circuit Ricardo Tormo in Valencia, Spain Proven GEN3 Evo iON Race tire maintains championship-level grip and consistent lap times Drivers completed six test sessions over four days, showcasing...
Aquilius Raises Largest Ever Asia Pacific Real Estate Secondaries Program at $1.1 Billion
AIP Secondary Fund II L.P., Aquilius' second real estate secondaries flagship fund, closed on total capital commitments of over US$750 million. The fund was significantly oversubscribed at the hard cap, surpassing its original US$700 million target....
Torch Relay for the 15th National Games Kicks Off, with Feng Xingya, Chairman and President of GAC Group, Serving as Torchbearer
HONG KONG, Nov. 2, 2025 /PRNewswire/ -- On November 2, the torch relay for the 15th National Games, of the People's Republic of China was launched simultaneously in four cities: Hong Kong, Macao, Guangzhou, and Shenzhen. Feng Xingya carried the...
SuperX Reports Annual Financial Results for FY2025; Sets Stage for AI Infrastructure Growth in FY2026
FY2025 Results Reflect Legacy Operations; Major Post-Year-End Milestones Lay Foundation for Next-Phase Expansion SINGAPORE, Nov. 1, 2025 /PRNewswire/ -- SuperX AI Technology Limited (NASDAQ: SUPX) ("SuperX" or "the Company"), formerly Super X AI...
Zhimeng Biopharma's investigational drug CB03-154 for amyotrophic lateral sclerosis has achieved the first patient first dose milestone in the phase 2/3 pivotal clinical trial.
SHANGHAI, Oct. 31, 2025 /PRNewswire/ -- Shanghai Zhimeng Biopharma Inc. ( "Zhimeng") announced that its self-developed new-generation potassium channel opener CB03-154 for the treatment of amyotrophic lateral sclerosis (ALS) has officially initiated...
Gansu Jinchang Power Supply Applies UAV for Remote Live-Line Installation of Spacers for the First Time
JINCHANG, China, Oct. 29, 2025 /PRNewswire/ -- Recently, the Transmission Operation and Maintenance Center of State Grid Gansu Jinchang Power Supply Company adopted live-line operation for installing phase-to-phase spacers for the first time. It...